Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.55
0.32%
After-hours: Aug 15, 2025, 04:12 PM EDT

Cognition Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
266K 252K 235K 93K
Gross Profit
-266K -252K -235K -93K
Operating Income
-53.97M -50.72M -43.55M -28.6M
Interest Income
n/a 27K 22.22M 17.45M
Pretax Income
-33.97M -25.79M -21.4M -11.72M
Net Income
-33.97M -25.79M 757K -10.29M
Selling & General & Admin
12.29M 13.53M 13.23M 10.03M
Research & Development
41.68M 37.2M 30.32M 18.57M
Other Expenses
n/a n/a -235K n/a
Operating Expenses
53.97M 50.72M 43.32M 28.6M
Interest Expense
25K n/a 28K 893K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
53.97M 50.72M 43.55M 28.6M
Income Tax Expense
n/a n/a -22.15M -1.43M
Shares Outstanding (Basic)
39.73M 29.99M 28.99M 22.23M
Shares Outstanding (Diluted)
39.73M 30.03M 28.99M 22.23M
EPS (Basic)
-0.85 -0.86 -0.74 -0.73
EPS (Diluted)
-0.85 -0.86 -0.74 -0.73
EBITDA
-33.68M -25.51M -21.13M -10.73M
EBIT
-33.95M -25.76M -21.37M -10.82M
Depreciation & Amortization
316K 252K 235K 93K